Methyl-CpG binding protein 2 (MeCP2) is another well-known 5mC reader that is involved in several cancers due to its ability to bind to methylated CpG dinucleotides on promoters of tumor suppressor genes and repress gene expression (Fig. 2; Klose et al. 2005). This evidence concerns the gene MECP2 and cancer.